Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mathew J. Loza"'
Autor:
Christian Herzmann, Ronald B. Turner, Mathew J. Loza, Robert Gordon, René Lutter, Sebastian L. Johnston, David Proud, Frédéric Baribaud, Brian Lipworth, Dave Singh, Alfred M. Del Vecchio, Philip E. Silkoff, Elliot S. Barnathan, Andreas Eich, Peter J. Sterk, Zuzana Diamant, Tjeert T. Mensinga, Patrick Branigan, Vibeke Backer, Scott A. Halperin, James E. Gern, Susan Flavin, Lani San Mateo
Background Human rhinoviruses (HRVs) commonly precipitate asthma exacerbations. Toll-like receptor 3, an innate pattern recognition receptor, is triggered by HRV, driving inflammation that can worsen asthma. Objective We sought to evaluate an inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e00d492722fb5f03a97012b0c9809d9a
http://hdl.handle.net/10044/1/51680
http://hdl.handle.net/10044/1/51680
Autor:
Sunil Nagpal, Mathew J. Loza, Carl Orr, Michele Bombardieri, Mihir D. Wechalekar, Suzanne Cole, Susanna Proudman, Malcolm D. Smith, Frances Humby, Brittney Scott, Ursula Fearon, Mary Canavan, Loui Madakamutil, Alice M. Walsh, Yanxia Guo, Douglas J. Veale, Joshua R. Friedman, Ian Anderson, Xuefeng Yin, Trudy McGarry, Costantino Pitzalis
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 2, p e0192704 (2018)
PLoS ONE, Vol 13, Iss 2, p e0192704 (2018)
Immune checkpoint blockade with therapeutic anti-cytotoxic T lymphocyte-associated antigen (CTLA)-4 (Ipilimumab) and anti-programmed death (PD)-1 (Nivolumab and Pembrolizumab) antibodies alone or in combination has shown remarkable efficacy in multip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343292ba893d6c5d530b5a09e107497c
https://doi.org/10.1371/journal.pone.0192704
https://doi.org/10.1371/journal.pone.0192704
